C

Curis
D

CRIS

2.45000
USD
-0.04
(-1.61%)
مغلق
حجم التداول
2,301
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
25,632,513
أصول ذات صلة
A
ARRY
-0.13000
(-2.53%)
5.01000 USD
C
CLDX
-0.020
(-0.10%)
20.660 USD
C
COCP
0.11000
(7.33%)
1.61000 USD
E
EXEL
0.700
(1.80%)
39.600 USD
N
NERV
-0.02000
(-1.14%)
1.73000 USD
المزيد
الأخبار المقالات

العنوان: Curis

القطاع: Healthcare
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.